THE EMERGENCE OF FLUOROQUINOLONES RESISTANCE AMONG MDR-TB PATIENTS AT A TERTIARY CARE FACILITY IN SIALKOT

AW KHAN; H SAEED; A TARIQ; A ASLAM

doi:10.54112/bcsrj.v2022i1.195

Authors

AW KHAN Department of Pulmonology, Govt. Allama Iqbal memorial teaching hospital Sialkot-Pakistan
H SAEED Department of Pulmonology
A TARIQ Department of Nephrology, Govt. Allama Iqbal memorial teaching hospital Sialkot-Pakistan
A ASLAM Department of Pulmonology, Aziz Fatima medical college Faisalabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2022i1.195

Keywords:

Fluoroquinolones, Tuberculosis, Multidrug-Resistant, Drug Resistance, Microbial, Antibiotic Resistance, Mycobacterium tuberculosis

Abstract

Pakistan is one of the countries that has a very high rate of multidrug-resistant tuberculosis (MDR-TB). The rising rate of drug resistance can be linked to several issues, including the private sector that is inadequately regulated, an increase in the number of prescribed antibiotics, and the practice of self-medication. A national anti-tuberculosis medication resistance survey found a high prevalence of fluoroquinolone resistance in multidrug-resistant tuberculosis patients. The purpose of this study was to evaluate fluoroquinolone resistance among multi drugs resistant TB patients. This study looked at the records of drug susceptibility testing, known as DST, for a total of 276 patients at Govt. Allama Iqbal memorial teaching hospital Sialkot, who was receiving treatment for tuberculosis. Eight-six patients fulfilling the inclusion criteria were included in the final analysis. The incidence of fluoroquinolone (ofloxacin) resistance was investigated, and its association with demographic factors and previous TB treatment categories was studied. When assessing fluoroquinolone resistance on DST, 44 (51.2%) patients resisted levofloxacin and 11 (12.8%) with moxifloxacin. In our study, the fluoroquinolones resistance was not statistically different in Cat-1 and Cat-2 patients. Similarly, age and gender also showed no significant difference in resistance to moxifloxacin and levofloxacin in MDR-TB patients. An alarmingly high percentage of MDR-TB infections showed resistance to fluoroquinolones. Based on our findings, it may be necessary to reevaluate current treatment recommendations for multidrug-resistant tuberculosis. There is an immediate need for stricter pharmacy regulations and better responsible involvement of private healthcare providers.

Downloads

Download data is not yet available.

References

Ahmad, N., Javaid, A., Sulaiman, S. A. S., Ming, L. C., Ahmad, I., and Khan, A. H. (2016). Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients. Brazilian Journal of Infectious Diseases 20, 41-47.

Ahmad, N., Khan, A. H., Sulaiman, S. A. S., and Javaid, A. (2015). Fluoroquinolones resistance in multidrug-resistant tuberculosis in Pakistan and suitability of guidelines recommended standardized regimen. International Journal of Mycobacteriology 4, 258.

Chughtai, A., Qadeer, E., Khan, W., Hadi, H., and Memon, I. (2013). Estimation of the contribution of private providers in tuberculosis case notification and treatment outcome in Pakistan. EMHJ-Eastern Mediterranean Health Journal, 19 (3), 213-218, 2013.

Cooke, G. S., Andrieux-Meyer, I., Applegate, T. L., Atun, R., Burry, J. R., Cheinquer, H., Dusheiko, G., Feld, J. J., Gore, C., and Griswold, M. G. (2019). Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. The lancet Gastroenterology & hepatology 4, 135-184.

Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., and Lessem, E. (2017). The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The lancet Respiratory medicine 5, 291-360.

Hasan, R., Jabeen, K., Ali, A., Rafiq, Y., Laiq, R., Malik, B., Tanveer, M., Groenheit, R., Ghebremichael, S., and Hoffner, S. (2010). Extensively drug-resistant tuberculosis, Pakistan. Emerging infectious diseases 16, 1473.

Jabeen, K., Shakoor, S., Chishti, S., Ayaz, A., and Hasan, R. (2011). Fluoroquinolone-resistant Mycobacterium tuberculosis, Pakistan, 2005–2009. Emerging infectious diseases 17, 566.

Khan, A. J., Khowaja, S., Khan, F. S., Qazi, F., Lotia, I., Habib, A., Mohammed, S., Khan, U., Amanullah, F., and Hussain, H. (2012). Engaging the private sector to increase tuberculosis case detection: an impact evaluation study. The Lancet infectious diseases 12, 608-616.

Laurence, Y. V., Griffiths, U. K., and Vassall, A. (2015). Costs to health services and the patient of treating tuberculosis: a systematic literature review. Pharmacoeconomics 33, 939-955.

Organization, W. H. (2013). "Global tuberculosis report 2013," World Health Organization.

Organization, W. H. (2022). "WHO operational handbook on tuberculosis. module 4: Treatment-drug-resistant tuberculosis treatment, 2022 update," World Health Organization.

Rich, M., and Jaramillo, E. (2008). "Guidelines for the programmatic management of drug-resistant tuberculosis," World Health Organization.

Shelby, P. W., Lia, M. P., and Israel, A. (2017). Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016. Journal of healthcare leadership, 47-57.

Tahseen, S., Qadeer, E., Khanzada, F., Rizvi, A., Dean, A., Van Deun, A., and Zignol, M. (2016). Use of Xpert® MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan. The International Journal of Tuberculosis and Lung Disease 20, 448-455.

Ullah, S., Daud, H., Dass, S. C., Fanaee-T, H., Kausarian, H., and Khalil, A. (2020). Space-time clustering characteristics of tuberculosis in Khyber Pakhtunkhwa Province, Pakistan, 2015–2019. International journal of environmental research and public health 17, 1413.

Vanaja, K., Banu, R., Reddy, L., Kumar, P. C., Srinivas, C., Rajani, T., and Shekar, H. (2016). A study on knowledge and awareness about tuberculosis in senior school children in Bangalore, India. indian journal of tuberculosis 63, 192-198.

Zegeye, A., Dessie, G., Wagnew, F., Gebrie, A., Islam, S. M. S., Tesfaye, B., and Kiross, D. (2019). Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis. PloS one 14, e0210422.